AVDL
Avadel Pharmaceuticals
AVDL
AVDL
75 hedge funds and large institutions have $126M invested in Avadel Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 24 increasing their positions, 21 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less capital invested
Capital invested by funds: $189M → $126M (-$62.7M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Holders
75
Holding in Top 10
–
Calls
$678K
Puts
$594K
Top Buyers
| 1 | +$1.64M | |
| 2 | +$991K | |
| 3 | +$833K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$793K |
| 5 |
BC
Broadfin Capital
New York
|
+$613K |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$9.45M | |
| 3 | -$6.54M | |
| 4 |
Morgan Stanley
New York
|
-$3.98M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$2.45M |